Top Industry News

Merck & Co. has started construction for a $3-billion, 400,000-square-foot pharmaceutical manufacturing facility at its site in Elkton, Virginia. The facility will serve as a Center of Excellence for Pharmaceutical…

The latest from CDMOs, CMOs, and suppliers featuring Cambrex, ACG, Syngene, Sharp Services, SK pharmteco, ProImmune, Seran BioScience, Aenova, Adare Pharma Solutions, Stevanato Group, Wilmington PharmaTech, and Aragen  Chemicals/Chemical API…

A roundup of news from Galderma, Alkermes/Avadel Pharmaceuticals, Regeneron/Celltrion, Takeda/Innovent Biologics, Takeda/Nabla Bio, Daiichi Sankyo/Bio Med X, Bio Med X/Gates Foundation, and Galapagos. Highlights below.   Mfg News * Dermatology Pharma Company Galderma…

At the DCAT Summit in Lugano, “Expedition Pharma: Innovation from a Patient-First Perspective,” held June 4–5, 2025, in Lugano, Switzerland, speakers emphasized the importance of innovation in formulation development and…

AstraZeneca has entered an agreement with the US government under which the company will have a three-year grace period for any tariffs resulting from an ongoing effort by the Trump Administration to impose pharmaceutical-industry…

AstraZeneca is investing $445 million to expand its manufacturing facility in Coppell, Texas. The expansion project will double the production of Lokelma (sodium zirconium cyclosilicate), a drug for treating hyperkalemia (high levels of potassium in the blood). The investment…

The latest from CDMOs, CMOs, and suppliers featuring MilliporeSigma, Bora Pharmaceuticals, Sterling Pharma Solutions, Ypsomed, Codis and LTS.   Biologics Manufacturing * MilliporeSigma To Acquire the Chromatography Business of JSR Life Sciences Formulation Development/Drug Product Manufacturing * Bora Pharmaceuticals Adding New High-Potency Liquid-Filled Hard Capsule…

A roundup of news from BMS/Orbital Therapeutics, Novo Nordisk/Omeros, BioNTech, BI/AimedBioBI/Accent Therapeutics, Merck KGaA/Siemens, Zenas BioPharma/InnoCare Pharma, Viatris/Aculys Pharma, Eli Lilly and Company and Ferring Pharmaceuticals. Highlights below.   Mfg News * BioNTech Receives $113 M in Funding for mRNA Vaccine Facility…

At the DCAT Summit at Lugano, “Expedition Pharma: Innovation from a Patient-First Perspective,” held June 4–5, 2025, in Lugano, Switzerland, pharmaceutical leaders emphasized that agility and innovation are not optional—they…

AstraZeneca has announced the location of a new $4.5-billion active pharmaceutical ingredient (API) manufacturing facility in Charlottesville, Albemarle County, Virginia, which will support manufacturing over a broad range of medicines,…